Guardant Health Inc. (GH) stock soared 5.08% in early trading on Wednesday, following a strong quarterly performance that prompted Piper Sandler to raise its price target on the company.
According to the news, Piper Sandler analyst David Westenberg raised the firm's price target on Guardant Health to $50 from $34, reflecting the company's solid financial results and positive outlook.
The stock price surge indicates investors' confidence in Guardant Health's prospects, as the company continues to innovate and expand its offerings in the healthcare sector.